Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an update.
Recordati Industria Chimica e Farmaceutica S.p.A. has announced an Ordinary Meeting of Shareholders scheduled for April 29, 2025. The agenda includes discussions on the financial statements for 2024, the appointment and remuneration of the Board of Directors, and a proposal for the purchase and disposal of treasury shares. This meeting is significant for stakeholders as it will address key governance and financial decisions that could impact the company’s strategic direction and shareholder value.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is a pharmaceutical company based in Milan, Italy, specializing in the development, production, and marketing of pharmaceuticals. The company focuses on treatments for rare diseases and specialty care, with a significant presence in the European market.
YTD Price Performance: 5.63%
Average Trading Volume: 34,780
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €11.03B
For an in-depth examination of REC stock, go to TipRanks’ Stock Analysis page.